Covered recipient · General Payments record
DAVID STUART JENCKS
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,817.51
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $337.49 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $88.27 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $83.46 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $44.75 | 2 |
| Braintree Laboratories, Inc. | $31.16 | 1 |
| GENZYME CORPORATION | $27.92 | 1 |
| Celgene Corporation | $23.81 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.10 | 1 |
| Lilly USA, LLC | $17.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.59 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103992237 | CMS |
| ABBVIE INC. | $19.64 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103992239 | CMS |
| ABBVIE INC. | $16.93 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103992241 | CMS |
| ABBVIE INC. | $17.57 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103992243 | CMS |
| ABBVIE INC. | $18.54 | 12/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103992245 | CMS |
| Boston Scientific Corporation | $83.46 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092339518 | CMS |
| Braintree Laboratories, Inc. | $31.16 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125515331 | CMS |
| Celgene Corporation | $23.81 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101082207 | CMS |
| GENZYME CORPORATION | $27.92 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139934305 | CMS |
| Intercept Pharmaceuticals, Inc. | $19.85 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113632548 | CMS |
| Intercept Pharmaceuticals, Inc. | $24.90 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113632546 | CMS |
| Lilly USA, LLC | $17.02 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136133703 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.10 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137588640 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.